UY27547A1 - METHOD FOR THE IDENTIFICATION OF TUMOR MARKING ENZYMES - Google Patents

METHOD FOR THE IDENTIFICATION OF TUMOR MARKING ENZYMES

Info

Publication number
UY27547A1
UY27547A1 UY27547A UY27547A UY27547A1 UY 27547 A1 UY27547 A1 UY 27547A1 UY 27547 A UY27547 A UY 27547A UY 27547 A UY27547 A UY 27547A UY 27547 A1 UY27547 A1 UY 27547A1
Authority
UY
Uruguay
Prior art keywords
enzymes
identification
tumor marking
marking
tumor
Prior art date
Application number
UY27547A
Other languages
Spanish (es)
Inventor
Nobuo Shimma
Isao Umeda
Hideo Ishituka
Hisafumi Okabe
Takuo Tsukuda
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY27547A1 publication Critical patent/UY27547A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)

Abstract

La presente invención se refiere a un método para la identificación de enzimas que se expresan preferencialmente en ciertos tejidos tumorales en comparación con tejidos o células normales de crecimiento rápido, la utilización de tales enzimas para el diseno del compuesto para generar una sustancia anticancerígena basados en dichas enzimas, sus sales farmacéuticamente aceptables así como la composición farmacéutica de las mismas.The present invention relates to a method for the identification of enzymes that are preferentially expressed in certain tumor tissues compared to normal rapidly growing tissues or cells, the use of such enzymes for the design of the compound to generate an anticancer substance based on said enzymes, their pharmaceutically acceptable salts as well as the pharmaceutical composition thereof.

UY27547A 2001-11-23 2002-11-22 METHOD FOR THE IDENTIFICATION OF TUMOR MARKING ENZYMES UY27547A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01127401 2001-11-23

Publications (1)

Publication Number Publication Date
UY27547A1 true UY27547A1 (en) 2003-06-30

Family

ID=35160944

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27547A UY27547A1 (en) 2001-11-23 2002-11-22 METHOD FOR THE IDENTIFICATION OF TUMOR MARKING ENZYMES

Country Status (4)

Country Link
CN (1) CN1911921A (en)
GT (1) GT200200241A (en)
UY (1) UY27547A1 (en)
ZA (1) ZA200403654B (en)

Also Published As

Publication number Publication date
ZA200403654B (en) 2005-05-24
CN1911921A (en) 2007-02-14
GT200200241A (en) 2003-06-20

Similar Documents

Publication Publication Date Title
YU44404A (en) Method for identification of tumor targeting enzymes
UY30498A1 (en) NEW CLASS OF BENZIMIDAZOLILO COMPOUNDS, ITS SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
CL2020002698A1 (en) Methyl Modifying Enzyme Modulators, Compositions and Uses of These
UY29300A1 (en) CHEMICAL COMPOUNDS
PE20081506A1 (en) ANSAMYCIN FORMULATIONS
SV2004001691A (en) NEW DERIVATIVES OF AROMATIC FLUOROGLYCOSIDS, MEDICINES CONTAINING COMPOUNDS AND THEIR USES
UY28990A1 (en) NEW DERIVATIVES OF BENZENE 1, 3-CARBON AMINO AS B-RAF INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE PROCESSES.
UY29781A1 (en) DIAZASPIRO SUBSTITUTE COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS OR SALTS, PREPARATION METHODS AND USES
DK1802274T3 (en) Use of cannabidiol in the inhibition of brain tumor cell migration
UY29092A1 (en) DERIVATIVES OF 4-OXO-3,4-DIHIDROQUINAZOLIN-6-CARBOXAMIDA, B-RAF INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
UY32315A (en) PIPERIDINE COMPOUNDS AND USES OF THE SAME-596
BRPI0620229A8 (en) formulation
UY30835A1 (en) 8-ALQUINILXANTINAS AND DERIVATIVES
UY37818A (en) COMBINATION INCLUDING PALBOCICLIB AND ACID 6- (2,4-DICLOROPHENIL) -5- [4 - [(3S) -1- (3-FLUOROPROPIL) PIRROLIDIN-3-IL] OXIFENIL] -8,9-DIHIDRO-7H- BENZO [7] ANULEN-2-CARBOXYL
UY31860A (en) PIRIDINES OF TIAZOLO AS INHIBITORS OF THE GIRASA DNA
CL2008002394A1 (en) Cyclic depsipeptide, or derivatives, kallikrein 7 inhibitors, obtained from chondromyces crocatus, method of obtaining and therapeutic uses.
UY30377A1 (en) FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA
CL2009000727A1 (en) Substituted n-hydroxy-3-phenylprop-2-enmide and n-hydroxy-3-phenylpropanamide derivative compounds; deacetylase enzyme inhibitors; its pharmaceutical composition; Useful in the treatment of cancer, tumors, psoriasis, Alzheimer's, among others.
NI201900094A (en) DEUTERATED IMIDAZO [4, 5-c] QUINOLIN-2-ONA TYPE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
BRPI0606639A2 (en) new process for the preparation of substituted indoles
UY28356A1 (en) DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATIONS OF THE SAME AND ITS USES
UA97401C2 (en) Improved taste-masking extrudates
NI200300045A (en) INHIBITORS OF TRIARILOXIARILOXIPIRIMIDIN-2,4,6-METALOPROTEINASE TRION.
DOP2018000218A (en) CONJUGATED ESTERASE C1 INHIBITOR AND ITS USES
BRPI0416188A (en) flavoring-containing drug formulations with improved pharmaceutical properties

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160617